Utah Company Promises Faster, Better 'Superbug' Test

211 views · Published 30 May 2013 · 2:29 · Indexed 28 October 2026

Channel: KUTV 2 News Salt Lake City · 2013 · News & Politics

Watch on YouTube

By Ladd Egan(KUTV) A Southern Utah-based company has announced that its infectious disease testing system will have exclusive rights to a new test for drug-resistant superbugs. DxNA LLC, located in St. George, says its test will offer hospitals and other care facilities quicker, cheaper and more detailed detection of Staphylococcus strains including MRSA. €œAntibiotic-resistant strains of Staph are a huge issue, a big problem in hospitals,€ said DxNA President and CEO David Taus. €œIf we can provide them answers immediately, this will affect treatment.€Superbugs cause hospital-acquired infections in surgical sites, around medical device implants, in the skin and soft tissue and are resistant to regular antibiotics. The Associated Press recently reported that in U.S. hospitals, 1 in 20 patients catch infections they didn€™t have when they arrived and that those infections are linked to an estimated 100,000 deaths every year. Under a new agreement, DxNA€™s portable testing system GeneSTAT will have the exclusive rights to Flagstaff, Arizona-based PathGene€™s €œNext Generation€ test which can identify and differentiate between three of the most common types of Staph. The GeneSTAT molecular-based analyzer is about the size of a toaster oven. The test it performs depends on the single-use cartridge inserted into the machine which contains a sample vial, control agent and a radio frequency identification tag which relays instructions on how to do the analysis.  €œThe idea was to have a simple, diagnostic device that could be taken right on sight,€ Taus said. €œYou could do bedside or onsite field testing.€Taus says the GeneSTAT will give health care workers unmatched speed and simplicity at a fraction of the cost of traditional laboratory testing. €œTo be able to get the same answers that we can provide in less than two hours, now takes 48-72 hours to get that result,€ he said. Company officials say with their technology, small hospitals in rural areas would be able to afford on-site testing and that larger hospitals could install small testing stations in emergency rooms to monitor results in real time. €œIt makes a huge difference,€ DxNA Chief Operating Officer Ernie Sumsion said of the quicker test. €œPhysicians cannot afford, in the interest of their patients, to wait even 12 hours on one of these infections.€DxNA says it will take about a year to get the superbug test ready for market. (Copyright 2013 Sinclair Broadcasting Group)

More from this channel